Molecular epidemiology: A tool for understanding mechanisms of disease

European Journal of Surgery, Supplement

Volumn 168, Issue 587, 2002, Pages 62-69

  Boffetta, Paolo ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Bias; Biomarkers; Confounding; Molecular epidemiology; Statistical power

Indexed keywords

AFLATOXIN; BIOLOGICAL MARKER;

CANCER RESEARCH; CARCINOGENESIS; CARCINOGENICITY; CHROMOSOME ABERRATION; CONFERENCE PAPER; DNA ADDUCT; EPIDEMIOLOGICAL DATA; HUMAN; MOLECULAR BIOLOGY; PRIORITY JOURNAL; TOBACCO; VIRUS INFECTION; WART VIRUS;

EID: 0036953513     PISSN: 1102416X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Ambrosone CB, Freudenheim J, Graham S, et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 1996; 276: 1494-1501.
2. Blot WJ, McLaughlin JK, Devesa SS, Fraumeni JF Jr. Cancers of the oral cavity and pharynx. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. New York: Oxford University Press 1996; 666-680.
3. Bonassi S, Hagmar L, Stromberg U, et al. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. Cancer Res 2000; 60: 1619-1625.
4. D'Errico A, Malats N, Vineis P, Boffetta P. Review of studies of selected metabolic polymorphisms and cancer. In: Vineis P, Malats N, Lang M, et al., eds, Metabolic polymorphisms and susceptibility to cancer (IARC Scientific Publications No. 148). Lyon: International Agency for Research on Cancer, 1999; 323-393.
5. Greenland S. Hierarchical regression for epidemiologic analyses of multiple exposures. Environ Health Perspect 1994; 102 (suppl 8): 33-39.
6. Hernandez TM, Hainaut P. A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database. Environ Health Perspect 1999; 106: 385-391.
7. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295-300.
8. International Agency for Research on Cancer. Aflatoxins. In: IARC monographs on the evaluation of carcinogenic risks to humans, Suppl. 7. Overall evaluations of carcinogenicity: an updating of IARC Monographs from Volume 1 to 42. Lyon: International Agency for Research on Cancer, 1987; 83-87.
9. International Agency for Research on Cancer. Aflatoxins. In: IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 56, Some naturally occurring substances: Food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon: International Agency for Research on Cancer, 1993; 245-395.
10. International Agency for Research on Cancer. Ethylene oxide. In: IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 60. Some industrial chemicals. Lyon: International Agency for Research on Cancer, 1994; 73-159.
11. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 64. Human papilloma viruses. Lyon: International Agency for Research on Cancer, 1995.
12. London SJ, Yuan JM, Chung FL, et al. Isothiocyanates, glutathione S-transferase MI and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet 2000; 356: 724-729.
13. Pearce N, de Sanjosé S, Boffetta P, Kogevinas M, Saracci R, Savitz D. Limitations of biomarkers of exposure in cancer epidemiology. Epidemiology 1995; 6: 190-194.
14. Perera FP, Weinstein IB. Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. J Chronic Dis 1982; 35: 581-600.
15. Perera FP. Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J Natl Cancer Inst 1996; 88: 496-509.
16. Ross RK, Yuan J-M, Yu MC, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992; 339: 943-946.
17. Rothman KJ, Greenland S. Modern epidemiology, 2. Philadelphia: Lippincott-Raven, 1996.
18. Rothman N. Epilogue. In: Schulte PA, Perera FP, eds. Molecular epidemiology: principles and practices. San Diego: Academic press, 1993; 565-569.
19. Santella RM, Weston A, Perera FP, et al. Interlaboratory comparison of antisera and immunoassays for benzo[a]-pyrene-diol-epoxide-I-modified DNA. Carcinogenesis 1988; 9: 1265-1269.
20. Schulte PA, Perera FP, eds. Molecular epidemiology: principles and practices. San Diego: Academic Press, 1993.
21. Schulte PA. A conceptual and historical framework for molecular epidemiology. In: Schulte PA, Perera FP, eds, Molecular epidemiology: principles and practices. San Diego: Academic Press. 1993; 3-44.
22. Schulte PA, Perera, FP. Transitional studies. In: Toniolo P, Boffetta P, Shuker DEG, Rothman N, Hulka B, Pearce N, eds. Application of biomarkers in cancer epidemiology (IARC Scientific Publications No. 142). Lyon: International Agency for Research on Cancer, 1997; 19-29.
23. Slattery ML, Potter JD, Samowitz W, Bigler J, Caan B, Leppert M. NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Cancer epidemiol biomarkers prev 1998; 7: 1097-1184.
24. Smith G, Wolf CR. Cytochrome P450 CYP2D6. In: Vineis P, Malats N, Lang M, et al. eds, Metabolic polymorphisms and susceptibility to cancer (IARC Scientific Publications No. 148). Lyon: International Agency for Research on Cancer, 1999; 209-229.
25. Taioli E. International collaborative study on genetic susceptibility to environmental carcinogens. Cancer Epidemiol Biomarkers Prev 1999; 8: 727-728.
26. Toniolo P, Boffetta P, Shuker DEG, Rothman N, Hulka B, Pearce N, eds. Application of biomarkers in cancer epidemiology (IARC Scientific Publications No. 142). Lyon: International Agency for Research on Cancer, 1997.
27. Truett J, Cornfield J, Kannel W. A multivariate analysis of the risk of coronary heart disease in Framingham. J Chronic Dis 1967; 20: 511-524.
28. Tucker JD, Eastmond DA, Littlefield LG. Cytogenetic end-points as biological dosimeters and predictors of risk in epidemiological studies. In: Toniolo P, Boffetta P, Shuker DEG, Rothman N, Hulka B, Pearce N, eds. Application of biomarkers in cancer epidemiology (IARC Scientific Publications No. 142). Lyon: International Agency for Research on Cancer. 1997; 185-200.
29. Vineis P. Sources of variation in biomarkers. In: Toniolo P, Boffetta P, Shuker DEG, Rothman N, Hulka B, Pearce N, eds. Application of biomarkers in cancer epidemiology (IARC Scientific Publications No. 142). Lyon: International Agency for Research on Cancer, 1997; 59-71.
30. Vineis P, Malats N, Lang M, et al., eds. Metabolic polymorphisms and susceptibility to cancer (IARC Scientific Publications No. 148). Lyon: International Agency for Research on Cancer, 1999.
31. Yang Q, Khoury MJ. Evolving methods in genetic epidemiology, III, Gene-environment interaction in epidemiologic research. Epidemiol Rev 1997; 19: 33-43.